Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

The Biotech Growth Trust (BIOG) Competitors

The Biotech Growth Trust logo
GBX 898 +2.00 (+0.22%)
As of 07:32 AM Eastern
Compare

BIOG vs. JPE, TMPL, OCI, BBGI, APAX, ICGT, IEM, RICA, CGT, and MUT

Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include JPMorgan Elect plc ­- Managed Growth (JPE), Temple Bar (TMPL), Oakley Capital Investments (OCI), BBGI Global Infrastructure (BBGI), Apax Global Alpha (APAX), ICG Enterprise Trust (ICGT), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Capital Gearing (CGT), and Murray Income Trust (MUT). These companies are all part of the "asset management" industry.

The Biotech Growth Trust vs. Its Competitors

JPMorgan Elect plc ­- Managed Growth (LON:JPE) and The Biotech Growth Trust (LON:BIOG) are both small-cap asset management industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

In the previous week, The Biotech Growth Trust had 1 more articles in the media than JPMorgan Elect plc ­- Managed Growth. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for JPMorgan Elect plc ­- Managed Growth. The Biotech Growth Trust's average media sentiment score of 0.63 beat JPMorgan Elect plc ­- Managed Growth's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company Overall Sentiment
JPMorgan Elect plc ­- Managed Growth Neutral
The Biotech Growth Trust Positive

The Biotech Growth Trust has lower revenue, but higher earnings than JPMorgan Elect plc ­- Managed Growth. JPMorgan Elect plc ­- Managed Growth is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan Elect plc ­- Managed Growth£104.78M0.00N/A£0.75N/A
The Biotech Growth Trust£87.94M2.92£83.83M£297.873.01

The Biotech Growth Trust has a net margin of 95.33% compared to JPMorgan Elect plc ­- Managed Growth's net margin of 0.00%. The Biotech Growth Trust's return on equity of 26.96% beat JPMorgan Elect plc ­- Managed Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan Elect plc ­- Managed GrowthN/A N/A N/A
The Biotech Growth Trust 95.33%26.96%12.39%

28.6% of The Biotech Growth Trust shares are held by institutional investors. 0.7% of The Biotech Growth Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

The Biotech Growth Trust beats JPMorgan Elect plc ­- Managed Growth on 8 of the 10 factors compared between the two stocks.

Get The Biotech Growth Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOG vs. The Competition

Export to Excel
MetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£256.55M£1.30B£6.49B£3.17B
Dividend YieldN/A4.40%4.17%5.04%
P/E Ratio3.0122.6514.34168.30
Price / Sales2.922,455.111,764.78464,808.10
Price / Cash87.7460.62127.5027.93
Price / Book0.831.395.286.98
Net Income£83.83M£265.04M£1.23B£5.89B
7 Day Performance0.90%0.13%0.12%0.16%
1 Month Performance9.51%1.51%2.70%49.92%
1 Year Performance-11.09%6.91%24.42%154.86%

The Biotech Growth Trust Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOG
The Biotech Growth Trust
N/AGBX 898
+0.2%		N/A-9.5%£256.55M£87.94M3.01N/A
JPE
JPMorgan Elect plc ­- Managed Growth
N/AN/AN/AN/A£1.00B£104.78M1,250.00N/A
TMPL
Temple Bar
N/AGBX 345.63
+0.8%		N/A+26.4%£988.77M£157.64M6.42N/A
OCI
Oakley Capital Investments
N/AGBX 560
+0.7%		N/A+7.2%£987.90M£99.08M11.22N/A
BBGI
BBGI Global Infrastructure
N/AGBX 138.50
flat		N/AN/A£984.71M£67.98M17.931,160
APAX
Apax Global Alpha
N/AGBX 163.62
+0.0%		N/A+10.1%£955.29M£9.05M277.59N/A
ICGT
ICG Enterprise Trust
N/AGBX 1,456
+0.4%		N/A+16.7%£940.99M£55.63M29.07N/ANews Coverage
Positive News
IEM
Impax Environmental Markets
N/AGBX 398
+0.4%		N/A+3.5%£923.96M£1.35M-99.00N/ANews Coverage
RICA
Ruffer Investment
N/AGBX 284.47
+0.2%		N/A+2.7%£915.35M£16.91M103.48N/A
CGT
Capital Gearing
N/AGBX 4,843.65
+0.1%		N/A+1.9%£900.79M£17.92M19.69N/A
MUT
Murray Income Trust
N/AGBX 896.69
-0.1%		N/A+2.8%£895.87M£97.96M9.88147,000Dividend Cut

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BIOG) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel